Drug Study
Drug Study
INDICATION
ACTION Competitivel y inhibits action of histamine on the H2 at receptor sites of parietal cells, decreasing gastric acid secretions.
CONTRAINDICA TION Contraindicated in patients hypersensitivity to drug and those with acute porphyria.
SIDE EFFECTS Jaundice, anaphylaxi s, angioede ma. Abdominal pain, blood in stool.
NURSING RESPONSIBILITY 1. Asses patient for abdominal pain. Note presence of blood in emesis, stool, or gastric aspirate. 2. Do not confuse Ranitidine with Rimantidine: dont confuse Zantac with Xanax or Zyrtec. 3. Instruct patient to take without regard to meals because absorption isnt affected by food. 4. Urge patient to avoid cigarette smoking because this may increase gastric acid secretion and worsen disease. 5. Advise patient to report abdominal pain and blood in stool or emesis.
Duodenal and gastric ulcer (short-term treatment); Brand pathologic Name: hypersecretor Zantac y conditions, such as Classificati Zollingeron: Ellison Antacid syndrome. Dose: 50g Frequency : every 8 hours Form: IV Route: Parenteral Maintenance therapy for duodenal or gastric ulcer. Gastroesopha geal reflux disease. Erosive esophagitis. Heartburn.
EENT: blurred Use cautiously in vision. patients with hepatic Other: dysfunction. burning Adjust dosage in and itching patients with at the impaired renal injection functions. site.
DRUG STUDY
DRUG Generic Name: Calcium gluconate Brand Name: Classificati on: Electrolyte and replacement solution Dose: Frequency: after the 4th BT. Form: IV INDICATI ON During exchange transfusio ns. ACTION Replaces calcium and maintains calcium level. CONTRAINDICA TION Contraindicated in cancer patients with bone metastases and in patients with ventricular fibrillation, hypercalcemia, hypophosphatem ia, or renal calculi. ADVERSE REACTION GI: irritation, constipation, chalky taste, hemorrhage, nausea, vomiting, thirst, abdominal pain. GU: polyuria, renal calculi Metabolic: hypercalcemia Skin: local reaction, including burning, necrosis, tissue sloughing, cellulites, soft tissue calcification with I.M. use, SIDE EFFECTS CNS: tingling sensations, sense of oppression or heat waves with I.V. use; syncope with rapid I.V. injection. CV: mild drop in blood pressure, vasodilation, bradycardia, arrhythmias, cardiac arrest with rapid I.V. injection NURSING RESPONSIBILITY 1. Use all calcium products with extreme caution in digitalized patients and patients with sarcoidosis and renal or cardiac disease. 2. Give I.M. injection in gluteal region in adults and in lateral thigh in infants. Use I.M route only in emergencies when no I.V. route is available because of irritation of tissue by calcium salts. 3. Monitor calcium levels frequently.
Route: Parenteral